More than 20 years' experience in biostatistics and programming, especially focusing on oncology drug development. He has worked on regulatory submission of mirvetuximab soravtansine, erlotinib, lapatinib, and bevacizumab. Previously worked as a statistical leader in ImmunoGen, Astellas, Genentech, GSK